Olympus Stock

JPY1,792.00

4.03% today

Tokyo, Sep 01, 08:15 am CET

ISIN

JP3201200007

Symbol

7733

Index

Nikkei 225

Sector

Health Care Equipment & Services

Industry

Health Care Equipment & Supplies

Overview Dividends Analysts Charts Strategies

Olympus Stock price

JPY1,802.50

-300.50 14.29% 5Y

Tokyo, Closing price Mon, Sep 01 2025

+80.00 4.64%

ISIN

JP3201200007

Symbol

7733

Index

Nikkei 225

Sector

Health Care Equipment & Services

Industry

Health Care Equipment & Supplies

Key metrics

Basic

Market capitalization

JPY2.0t

Enterprise Value

JPY2.0t

Net debt

JPY31.0b

Cash

JPY245.7b

Shares outstanding

1.1b

Valuation (TTM | estimate)

P/E

17.3 | 20.4

P/S

2.0 | 2.0

EV/Sales

2.1 | 2.0

EV/FCF

24.3

P/B

2.7

Dividends

DPS

JPY18.00

Yield 1Y | 5Y

1.0% | 0.7%

Growth 1Y | 5Y

12.5% | 19.1%

Payout 1Y | 3Y

9.0% | 11.9%

Increased

6 Years

Financials (TTM | estimate)

Revenue

JPY969.0b | JPY995.1b

EBITDA

JPY232.7b | JPY234.0b

EBIT

JPY167.2b | JPY26.6b

Net Income

JPY112.3b | JPY95.1b

Free Cash Flow

JPY81.8b

Growth (TTM | estimate)

Revenue

0.6% | -0.2%

EBITDA

69.3% | 5.2%

EBIT

135.8% | -85.9%

Net Income

576.7% | -19.3%

Free Cash Flow

45.4%

Financial Health

Equity Ratio

52.5%

Return on Equity

15.7%

ROCE

15.4%

ROIC

14.1%

Debt/Equity

0.4

EPS

JPY99.5

FCF per Share

JPY72.5

Short interest

Employees

29k

Rev per Employee

JPY34.6m

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

Get Started for Free Today

Olympus Stock Analysis

Unlock Scores for Free

??

20 Analysts have issued a Olympus forecast:

12x Buy

60%

8x Hold

40%

More details on Analyst Estimates Including Price Targets

20 Analysts have issued a Olympus forecast:

Buy

60%

Hold

40%

Analyst Estimates with Stock Price Targets

Financial data from Olympus

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Jun '25		+/- %
Revenue	969,023 969,023	1% 1% 100%
- Direct Costs	306,403 306,403	4% 4% 32%
Gross Profit	662,620 662,620	3% 3% 68%
- Selling and Administrative Expenses	499,008 499,008	3% 3% 51%
- Research and Development Expense	- -	- -
EBITDA	232,658 232,658	69% 69% 24%
- Depreciation and Amortization	65,484 65,484	2% 2% 7%
EBIT (Operating Income) EBIT	167,174 167,174	136% 136% 17%
Net Profit	112,263 112,263	577% 577% 12%

In millions JPY.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Company Profile

Olympus Corp. is engaged in the manufacture and sale of precision machineries and instruments. It operates through the following segments: Medical Systems, Life Sciences and Industrial, Imaging Systems, Information and Communications, and Others. The Medical Systems segment covers endoscopes, and endoscopic surgery and therapy. The Life Sciences and Industrial segment manufactures and sells biological and industrial microscopes, industrial endoscopes, non-destructive testing equipment, and printers. The Imaging Systems segment deals with digital cameras and recording devices. The Information and Communication segment sells mobile terminals such as mobile phones. The Others segment includes biomaterial manufacturing and sales, and system development. The company was founded by Takeshi Yamashita on October 12, 1919 and is headquartered in Tokyo, Japan.

Head office	Japan
CEO	Yasuo Takeuchi
Employees	28,838
Founded	1919
Website	www.olympus.co.jp

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now